NeXtGen Biologics

Alachua, FL · Founded 2014 · Privately Held (backing)

Developer of extracellular matrix biomaterial products designed to harness axolotl-derived extracellular matrix components for tissue regeneration. NeXtGen Biologics is based in Alachua, FL and was founded in 2014. Its last reported valuation was $6.6 million in Nov 2015. It has raised $6.7 million across 2 recorded rounds; the latest was a $2.2 million seed round in Dec 2018.

Last reported valuation
$6.6M
Oct 2026
Priced at
—
Total raised
$6.7M
Last round
Seed Round
Dec 2018
What is NeXtGen Biologics worth?
$6.6Mlast reported valuation · Oct 2026

NeXtGen Biologics's last reported valuation, Nov 2015. Nothing priced has surfaced since.

Free account
More of NeXtGen Biologics with a free account
  • ·Watch NeXtGen Biologics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

NeXtGen Biologics funding history

2 rounds
DateRoundRaisedPost-money
Dec 2018Seed Round$2.2M▮
Aug 2014Debt$500K▮
Unlock post-money valuations

Membership and data by Private Market View

NeXtGen Biologics valuation

NeXtGen Biologics's last reported valuation was $6.6 million in Nov 2015. No priced round, secondary trade or fund mark has surfaced since.

How much has NeXtGen Biologics raised?

NeXtGen Biologics has raised $6.7 million in total; 2 of its rounds are on record. The largest on record was a $500,000 debt round in Aug 2014; the most recent was a $2.2 million seed round in Dec 2018.

NeXtGen Biologics has filed 7 Form Ds with the SEC since 2014, most recently in Sep 2025 ($130,000 sold to 3 investors).

How NeXtGen Biologics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For NeXtGen Biologics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about NeXtGen Biologics

What is NeXtGen Biologics worth?
NeXtGen Biologics is valued at $6.6M as of Oct 2026. NeXtGen Biologics's last reported valuation, Nov 2015. Nothing priced has surfaced since.
How much has NeXtGen Biologics raised?
NeXtGen Biologics has raised $6.7M in total funding across 2 recorded rounds.
When did NeXtGen Biologics last raise?
NeXtGen Biologics last raised in Dec 2018 (Seed Round), raising $2.2M.